William W. L. Wong, PhD
School of Pharmacy, University of Waterloo
Toronto Health Economics and Technology Assessment Collaborative (THETA)
10A Victoria Street S
Kitchener,
ON
Canada
N2G1C5
Papers:
INFECTIOUS DISEASE MODELING INTEREST GROUP MEETING
COST-EFFECTIVENESS ANALYSIS OF DRUGS FOR CHRONIC HEPATITIS C INFECTION: INFORMING ON LISTING DECISIONS OF INTERFERON-FREE DIRECT-ACTING ANTIVIRAL REGIMENS IN CANADA
IS VERY EARLY HTA POSSIBLE? A MATHEMATICAL FRAMEWORK OF USING ECONOMIC EVALUATION MODELS TO INFLUENCE THE DIRECTION OF DRUG DISCOVERY
A SYSTEMATIC REVIEW AND META-ANALYSIS OF HEALTH UTILITIES IN CHRONIC HEPATITIS C PATIENTS
HEALTH UTILITIES IN CHRONIC HEPATITIS C PATIENTS WITH LATE-STAGE LIVER DISEASE